Managing drug–drug interactions with new direct‐acting antiviral agents in chronic hepatitis C

Several direct‐acting antiviral agents (DAAs) have marketing authorization in Europe and in the USA and have changed the landscape of hepatitis C treatment: each DAA has its own metabolism and drug–drug interactions (DDIs), and managing them is a challenge. To compile the pharmacokinetics and DDI da...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Clin Pharmacol
Asıl Yazarlar: Talavera Pons, Sarah, Boyer, Anne, Lamblin, Geraldine, Chennell, Philip, Châtenet, François‐Thibault, Nicolas, Carine, Sautou, Valérie, Abergel, Armand
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2016
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237698/
https://ncbi.nlm.nih.gov/pubmed/27530469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13095
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller